z-logo
open-access-imgOpen Access
A role for CXC chemokine receptor‐2 in the pathogenesis of urogenital Chlamydia muridarum infection in mice
Author(s) -
Lee Hyo Y.,
Schripsema Justin H.,
Sigar Ira M.,
Lacy Sha R.,
Kasimos John N.,
Murray Candace M.,
Ramsey Kyle H.
Publication year - 2010
Publication title -
fems immunology & medical microbiology
Language(s) - English
Resource type - Journals
eISSN - 1574-695X
pISSN - 0928-8244
DOI - 10.1111/j.1574-695x.2010.00715.x
Subject(s) - cxc chemokine receptors , biology , immunology , chemokine receptor , chlamydia , chemokine , cxcl9 , inflammation
We tested the hypothesis that a specific chemokine receptor, CXC chemokine receptor‐2 (CXCR2), mediates acute inflammatory damage during chlamydial urogenital infection, which ultimately leads to the chronic sequelae of hydrosalpinx – a surrogate marker of infertility. Homozygous CXCR2 genetic knockouts (CXCR2−/−), heterozygous littermates (CXCR2+/−) or homozygous wild‐type (wt) controls (CXCR2+/+) were infected intravaginally with Chlamydia muridarum . Although no change was observed in the infection in the lower genital tract based on CXCR zygosity, a delay in the ascension of infection into the upper genital tract was seen in CXCR2−/− mice. Significantly elevated peripheral blood neutrophil counts were observed in CXCR2−/− mice when compared with controls. Reduced rates of acute inflammatory indices were observed in the affected tissue, indicating reduced neutrophil extravasation capacity in the absence of CXCR2. Of note was a reduction in the postinfection development of hydrosalpinx that correlated with CXCR2 zygosity, with both CXCR2−/− (13%) and their CXCR2+/− (35%) littermates displaying significantly lower rates of hydrosalpinx formation than the wt CXCR2‐sufficient mice (93%). We conclude that CXCR2 ligands are a major chemotactic signal that induces damaging acute inflammation and the resulting chronic pathology during the repair phase of the host response, but are dispensable for the resolution of infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here